The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People
暂无分享,去创建一个
[1] C. Weiss,et al. The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People , 2019, Drugs & Aging.
[2] Thomas Kahan,et al. [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.
[3] M. Wehling,et al. A systematic review and novel classification of listing tools to improve medication in older people , 2019, European Journal of Clinical Pharmacology.
[4] I. Kunnamo,et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy , 2018, BMC Family Practice.
[5] D. O’Mahony,et al. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis , 2018, Age and ageing.
[6] M. Illario,et al. A case study of polypharmacy management in nine European countries: Implications for change management and implementation , 2018, PloS one.
[7] M. Wensing,et al. Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial , 2017, Implementation Science.
[8] L. Jacob,et al. Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany , 2017, Journal of diabetes science and technology.
[9] C. Walker,et al. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia , 2016, Age and ageing.
[10] B. Vaes,et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. , 2016, British journal of clinical pharmacology.
[11] P. Gallagher,et al. Prevention of Hospital‐Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial , 2016, Journal of the American Geriatrics Society.
[12] C. Weiss,et al. The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly , 2016, Drugs & Aging.
[13] C. Weiss,et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. , 2016, Age and ageing.
[14] Ngaire Kerse,et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review , 2015, BMJ Open.
[15] Mary Jordan Samuel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.
[16] A. Harugeri,et al. Elderly patients’ participation in clinical trials , 2015, Perspectives in clinical research.
[17] John B. Young,et al. Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design. , 2015, Age and ageing.
[18] D. Grandt,et al. Influence of hospitalization on prescribing safety across the continuum of care: an exploratory study , 2015, BMC Health Services Research.
[19] Nicole Brandt,et al. Prevalence of Potentially Inappropriate Medication Use in Older Adults Using the 2012 Beers Criteria , 2015, Journal of the American Geriatrics Society.
[20] Thomas Bürkle,et al. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs , 2015, Pharmacoepidemiology and drug safety.
[21] Paul Gallagher,et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.
[22] C. Vu,et al. Inappropriate use of proton pump inhibitors in a local setting. , 2014, Singapore medical journal.
[23] Joseph Hanlon,et al. Clinical consequences of polypharmacy in elderly , 2014, Expert opinion on drug safety.
[24] C. Weiss,et al. Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly , 2013, Drugs & Aging.
[25] S. Wyke,et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.
[26] G. Watts. Why the exclusion of older people from clinical research must stop , 2012, BMJ : British Medical Journal.
[27] Martin Wehling,et al. GUIDELINE‐DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS , 2011, Journal of the American Geriatrics Society.
[28] M. Egger,et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.
[29] M. Wehling,et al. [Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA]. , 2008, Deutsche medizinische Wochenschrift.
[30] R. Page,et al. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. , 2006, The American journal of geriatric pharmacotherapy.
[31] H. Quan,et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.
[32] M. Beers,et al. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.
[33] C. Weiss,et al. The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People , 2018, Drugs & Aging.
[34] M. Wehling. Drug Therapy for the Elderly , 2013 .
[35] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[36] D. Rolfson,et al. Clinical Interventions in Aging Dovepress Physicians' Use of Computerized Clinical Decision Supports to Improve Medication Management in the Elderly – the Seniors Medication Alert and Review Technology Intervention , 2022 .